🇺🇸 MRK — Merck & Co., Inc.

Healthcare Compra
← Volver

Precio actual

150,33 USD

Máx. histórico

156,92

10 días

Caída desde máximo

-4,20%

Rango 52 semanas

77,58 – 156,92

Variación hoy

-1,32%

Cierre anterior

152,34

Rango de hoy

150,09 – 152,22

Volumen hoy

4.298.143

Información
Nombre completo
Merck & Co., Inc.
Divisa
USD
Mercado
NYSE
Sector
Healthcare
Industria
Drug Manufacturers - General
Empleados
73.000
PER ⓘ
122,22 (puede no estar actualizado)
Dividend yield
2,23% (puede no estar actualizado)
Precio objetivo analistas
148,73 USD (puede no estar actualizado)
Primera cotización
02/01/1962
Precio actualizado
hace 2 días
Sobre la empresa

Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.

Dividendos repartidos Total últimos 12 meses: 3,3600 USD · Yield: 2,24%
Fecha de pago Importe por participación
13/06/2011 0,3626 USD
11/03/2011 0,3626 USD
13/12/2010 0,3626 USD
13/09/2010 0,3626 USD
11/06/2010 0,3626 USD
11/03/2010 0,3626 USD
11/12/2009 0,3626 USD
02/09/2009 0,3626 USD
04/06/2009 0,3626 USD
04/03/2009 0,3626 USD
03/12/2008 0,3626 USD
03/09/2008 0,3626 USD
04/06/2008 0,3626 USD
05/03/2008 0,3626 USD
05/12/2007 0,3626 USD
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
29/11/2018 73,65 74,89 73,58 74,34 +0,88% 1,77% 11.429.174
28/11/2018 73,28 73,82 72,78 73,69 +1,17% 1,42% 12.625.675
27/11/2018 71,63 73,02 71,63 72,84 +1,19% 1,93% 15.325.533
26/11/2018 71,56 72,28 71,36 71,98 +1,03% 1,28% 11.407.061
23/11/2018 70,73 71,85 70,62 71,25 -0,16% 1,74% 3.690.846
21/11/2018 71,49 71,63 70,78 71,36 +0,01% 1,19% 9.489.116
20/11/2018 72,53 72,86 71,23 71,36 -2,06% 2,25% 14.240.014
19/11/2018 72,73 73,10 72,13 72,85 +0,38% 1,34% 17.210.675
16/11/2018 71,32 72,76 71,14 72,58 +1,63% 2,27% 14.384.010
15/11/2018 70,13 71,44 69,78 71,41 +1,01% 2,37% 12.549.171
14/11/2018 71,52 71,53 70,31 70,70 -0,70% 1,71% 9.936.193
13/11/2018 71,77 71,82 70,62 71,19 -0,11% 1,68% 16.587.430
12/11/2018 71,69 71,82 70,64 71,27 -0,23% 1,65% 14.679.022
09/11/2018 72,39 72,51 71,37 71,43 -0,82% 1,57% 15.359.802
08/11/2018 71,46 72,22 71,20 72,02 +0,53% 1,43% 13.634.690
07/11/2018 70,71 71,88 70,46 71,64 +2,41% 2,01% 19.566.684
06/11/2018 69,60 70,42 69,42 69,95 +0,26% 1,44% 10.737.913
05/11/2018 68,66 70,20 66,91 69,77 +1,18% 4,79% 12.922.364
02/11/2018 70,20 70,32 68,34 68,96 -1,16% 2,83% 13.517.838
01/11/2018 70,42 70,65 69,34 69,77 -0,67% 1,86% 14.507.988
31/10/2018 70,05 71,08 69,44 70,24 +1,02% 2,34% 16.624.529
30/10/2018 68,41 69,62 68,23 69,53 +1,99% 2,04% 19.845.976
29/10/2018 68,10 69,69 67,32 68,18 +1,49% 3,47% 19.743.901
26/10/2018 66,57 67,54 65,73 67,18 +0,63% 2,72% 17.764.229
25/10/2018 63,87 67,34 63,07 66,76 -0,82% 6,68% 21.553.692
24/10/2018 68,53 69,31 67,01 67,31 -2,16% 3,36% 15.348.170
23/10/2018 68,86 69,10 67,96 68,80 -0,65% 1,66% 12.116.871
22/10/2018 69,63 70,12 68,56 69,25 +0,30% 2,25% 12.486.186
19/10/2018 68,99 69,33 68,65 69,04 +0,19% 1,00% 15.210.043
18/10/2018 68,85 69,08 68,15 68,90 +0,54% 1,36% 12.812.848